|
|||||||||||||||||||
|
|||||||||||||||||||
| 1. Policy. | |||||||||||||||||||
| The Journal will entertain research papers for publication under the following categories : | |||||||||||||||||||
| (a) | original research articles/notes | ||||||||||||||||||
| (b) | invited reviews (including Mini reviews), and | ||||||||||||||||||
| (c) | editorial commentary and news. | ||||||||||||||||||
It shall cover entire spectra of pharmaceutical research like conventional fields of Pharmaceutical chemistry, Pharmaceutics, Pharmacognosy and Pharmacology as well as those related to synthesis and processing of pharmaceuticals, molecular modeling, rational drug design, combinatorial and computational chemistry, characterization, toxicity studies, pharmacological evaluation, product development, industrial pharmacy, pharmaceutical technology, dosage form design, targeted drug delivery, stability of drugs, biopharmaceutics, pharmacokinetics, pharmacodynamics, pro-drug concept, pharmaceutical analysis, standardization and evaluation of raw materials and formulations, clinical pharmacy, adverse drug reactions, therapeutic drug monitoring, metabolic disposition of bioactive agents, pharmaceutical engineering, protein - peptide chemistry, biotechnology directly related to pharmaceutical technology, phytochemistry, phytopharmaceuticals, nutraceuticals, herbal drug research, phytopharmacology, regulations on drug development and any other novel vista in pharmaceutical research. Original research article should be a comprehensive description of significant findings, whereas notes shall be limited to 1500 words. Review articles updating current topics shall be entertained by invitation only. A commentary on any specific field covered by the Journal shall be limited to 500 words without any figure or table. Critical commentary on any article of this Journal shall be referred to the author(s) of the original paper for opinion and accepted response shall be published in the same issue. All papers will be evaluated for scientific content, technical importance and significance by two independent reviewers of international repute and editor |
|||||||||||||||||||
| 2. Preparation of text. | |||||||||||||||||||
| (i) | General guidelines. The original text must be printed on laser printer, doublespaced on 8.5-x11-inch/ A4 size paper on one side only, original inked drawings of structural formulas, figures and original black and white print of photographs must be attached for direct reproduction. Additional sets may be photoduplicated copies. Only standard abbreviations should be used throughout the text. Any nonstandard abbreviation must be defined in the text following first use. Author(s) should provide correct nomenclature conforming with current international usage, similar to those used by Chemical Abstracts Service, the International Union of Pure and Applied Chemistry, and the International Union of Biochemistry and Molecular Biology etc. Only chemical/generic names for drugs should be used throughout the text. After the first mention, any identification/abbreviation may be used. As far as possible trade names and laboratory codes should be avoided. To establish identity and purity of new compounds, sufficient data including elemental analysis must be presented Illustrations must fit one-or two-column format of the journal. Chemical structures should be accurately drawn in single or double column width and be submitted as high contrast material for direct reproduction. A pattern should be presented as simple cross-hatch design. A single column drawing will be preferred. The column width is given below : |
||||||||||||||||||
|
|||||||||||||||||||
Spectral data : Routine spectral data for each compound need not be included in the text. For novel compounds and in structural elucidation, to interpret band shape or structure, it should be incorporated in the text. Biological data : Biological data may be presented as numerical expressions or in graphical form. Novel biological experimental procedure must be described at length/already published procedures must be referred in the text to enable others to repeat the same. Statistical significance of biological data is important. Doses and concentrations should be expressed as molar quantities. The routes of administration of test compounds and vehicles should be included. Author(s) should write in clear, concise English. Where English is NOT the first language we strongly recommend that the text be reviewed for English grammar prior to submission. The responsibility for all aspects of text preparation rests with the authors. Extensive changes or rewriting of the text will not be undertaken by the editors. |
|||||||||||||||||||
| (ii) | Electronic version. General
guidelines : The final accepted version of the paper must
be submitted in electronic form along with a hardcopy version of
the same. The version on the disk MUST exactly match the final version
accepted and the hardcopy. The entire text including the heading,
abstract, body of the paper, figure captions, scheme or chart captions,
tabular material, footnotes, and references should be in one file,
with the complete text first followed by tabular materials exactly
in the sequence in which it has to be printed . It is best to use
the fonts “Times” and “Symbol”. |
||||||||||||||||||
| (iii) | Format of text :
Heading of the paper should be on a separate page, with author’s
names, complete address of the laboratory where the research was
conducted, name & address of the corresponding author with telephone
number and e-mail ID. Separate sheet should be used for the abstract.
References and footnotes, tables and figure legends should be grouped
on separate sheets, in proper sequence. Each page should be numbered
consecutively. Current address of every author, if different, should
be given on the title page with a numerical superscript and footnote. |
||||||||||||||||||
| (iv) | Heading : Heading
of the paper is very useful for easy reference and retrieval. It
should reflect the content. Symbols, formulas, or arbitrary abbreviations
should not be included in it except chemical symbols for isotopically
labeled compounds. |
||||||||||||||||||
| (v) | Abstract : The
abstract should be shelf explanatory (limited to 200 words in one
paragraph) suitable for reproduction without change. Footnotes or
undefined abbreviations need not be used. |
||||||||||||||||||
| (vi) | Key words :
Maximum five words in italics may be used, each separated by semicolon(;).
Key words should appear immediately after the abstract on the same
page. |
||||||||||||||||||
| (vii) | Experimental : The
experimental procedures should be given in detail to enable others
to repeat them. Names of products and manufacturers (with address)
must be mentioned. Brand names may be used only once in the manuscript.
On subsequent occasions they may be identified as “product
X” or "formulation Y", etc. Novel experimental procedures
should be explained at length, and published ones should be identified
by citation. The purity of compounds and description(s) of the method(s)
used to verify the same should be included in this section. Strength of the reagents should be given accurately. Precautions for handling hazardous chemicals and dangerous procedures should be clearly mentioned and precautions to be observed while handling them must be explained or references cited. |
||||||||||||||||||
| (viii) | Results : The
results of the experiment should be presented concisely. Tables
and figures should be devised in such a manner that the findings
are accurately conveyed. The same data should not be used for more
than one figure or table. Interpretation of the data should be given
in the discussion. |
||||||||||||||||||
| (ix) | Tables : Tables
are effective means of presentation. Tables should be numbered consecutively,
and provided with caption. Footnotes should be identified by lower
case letters and cited in the tables as italicized superscripts.
All tables should be cited in the text. |
||||||||||||||||||
| (x) | Supplementary information
: The journal will entertain any type of supplementary
figures or data like, reproductions of spectra, equipment, tables,
detailed discussion of related findings, etc. For the format of
such information any International Journal may be referred. It may
be submitted in quadruplicate on 8.5- x 11 –inch/A4 Paper,
which may be reproduced directly. Legends for figures, spectra,
etc., must be given on the figures, spectra itself. |
||||||||||||||||||
| (xi) | Discussion :
The discussion must interpret the results and relate them to existing
knowledge on the topic in as lucid a manner as possible, avoiding
repetition or duplication of information. It should not be unnecessarily
lengthy. |
||||||||||||||||||
| (xii) | Acknowledgments :
The author should acknowledge advice from colleagues, financial/technical
assistance, gifts, etc. after obtaining consent from the people
whose assistance is acknowledged. |
||||||||||||||||||
| (xiii) | References : The
references must be numbered consecutively in order of mention in
the text, with numbers as superscripts. The author must ensure perfection
of the references. It should be typed double-spaced on separate
page(s) at the end of the text. Formal pattern of reference presentation
is given below: For journals: Morris KR, et al. Int J Pharm. 1994;
105: 209. For edited books: Flynn GL. In Topical Drug Bioavailability,
Bioequivalence, and Penetration. Shah VP, Maibach HI, eds. New York:
Plenum Press, 1993, p 369. Formally accepted papers may be referred
as “in press” and For other communications “unpublished
data” may be used, after names of authors. |
||||||||||||||||||
| 3. | Proofs and
Reprints : Accepted paper’s proofs will be sent
to the author for verification against the original and appropriate
corrections made. An order form for reprints will be sent with the
proofs. Please return the reprint order form with a cheque of Rs.1000/=(India)/US$100(abroad)
in favor of Journal of Pharmaceutical Research, Bangalore. Reprints
will be posted within 15 days after printing the journal. |
||||||||||||||||||
| 4. | Forwarding
Address : Two copies of the manuscript must be submitted
together with a forwarding letter and a signed Copyright Transfer
Agreement to the Chief Editor, Journal of Pharmaceutical Research,
Krupanidhi College of Pharmacy, #5, Sarjapur Road, Koramangala,
Bangalore-560034. India. Email- krupanidhi2003@rediffmail.com. Correspondence
regarding accepted papers, proofs, and reprints should be addressed
to the Chief Editor directly. |
||||||||||||||||||
Click here to Download PDF Format 
|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||
 |
| © Copyright 2010 - 2011 all rights reserved Journal of Pharmaceutical Research |